Izzah Athirah Rosli

Ms. Izzah Athirah Rosli

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NMNur Hasnah Maamor
Nur Hasnah Maamor
NMNor Asiah Muhamad
Nor Asiah Muhamad
NDNor Soleha Mohd Dali
Nor Soleha Mohd Dali
FLFatin Norhasny Leman
Fatin Norhasny Leman
IRIzzah Athirah Rosli
Izzah Athirah Rosli
NLNai Ming Lai
Nai Ming Lai
This review aimed to systematically compare and pool the prevalence of all the known evidence on caregiver hesitancy and to describe the factors influencing vaccine hesitancy among caregiver worldwide such as COVID-19, MMR, Influenza, HPV and others. We searched article from few electronic databases (PubMed, CENTRAL, ProQuest, and Web of Science) from inception to August 2023 using specific keywords for example caregiver, parents, prevalence, factor, hesitancy, and others. We included population-based studies that reported the prevalence of caregiver hesitancy. We used random-effects meta-analyses for pool prevalence estimates of caregiver hesitancy. A total of 765 studies met our inclusion criteria, containing data on 38,210,589 caregivers from seven regions across the globe. Overall or pool prevalence of vaccine hesitancy among caregiver is 25.0% (95% CI: 0.22–0.27, I2 = 99.91%, p = 0.001). Based on the evidence gathered, vaccine hesitancy was found to be religious sentiments, personal beliefs, perceived safety concerns, and a desire for more information from healthcare providers, along with factors related to availability, accessibility, affordability, and acceptability of vaccinations. Vaccine safety and efficiency have been identified as the main factor for caregiver vaccine hesitancy globally with a prevalence of 91.4%. Trial registration PROSPERO registration number: CRD42022331629. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022331629.

19 July 2023 in Interactive Journal of Medical Research
Verified
Journal Article
Open access
NMNor Asiah Muhamad
Nor Asiah Muhamad
NMNur Hasnah Maamor
Nur Hasnah Maamor
FLFatin Norhasny Leman
Fatin Norhasny Leman
Zuraifah Asrah MohamadZuraifah Asrah Mohamad
Zuraifah Asrah Mohamad
Sophia Karen BakonSophia Karen Bakon
Sophia Karen Bakon
MHMuhammad Radzi Abu Hassan
Muhammad Radzi Abu Hassan
Background: Nonalcoholic fatty liver disease (NAFLD) is one of the common causes of chronic liver disease globally. Obesity, metabolic diseases, and exposure to some environmental agents contribute to NAFLD. NAFLD is commonly considered a precursor for some types of cancers. Since the leading causes of death in people with NAFLD are cardiovascular disease and extrahepatic cancers, it is important to understand the mechanisms of the progression of NAFLD to control its progression and identify its association with extrahepatic cancers. Thus, this review aims to estimate the global prevalence of NAFLD in association with the risk of extrahepatic cancers. Objective: We aimed to determine the prevalence of various cancers in NAFLD patients and the association between NAFLD and cancer. Methods: We searched PubMed, ProQuest, Scopus, and Web of Science from database inception to March 2022 to identify eligible studies reporting the prevalence of NAFLD and the risk of incident cancers among adult individuals (aged ≥18 years). Data from selected studies were extracted, and meta-analysis was performed using random effects models to obtain the pooled prevalence with the 95% CI. The quality of the evidence was assessed with the Newcastle-Ottawa Scale. Results: We identified 11 studies that met our inclusion criteria, involving 222,523 adults and 3 types of cancer: hepatocellular carcinoma (HCC), breast cancer, and other types of extrahepatic cancer. The overall pooled prevalence of NAFLD and cancer was 26% (95% CI 16%-35%), while 25% of people had NAFLD and HCC (95% CI 7%-42%). NAFLD and breast cancer had the highest prevalence out of the 3 forms of cancer at 30% (95% CI 14%-45%), while the pooled prevalence for NAFLD and other cancers was 21% (95% CI 12%-31%). Conclusions: The review suggests that people with NAFLD may be at an increased risk of cancer that might not affect not only the liver but also other organs, such as the breast and bile duct. The findings serve as important evidence for policymakers to evaluate and recommend measures to reduce the prevalence of NAFLD through lifestyle and environmental preventive approaches. Trial Registration: PROSPERO CRD42022321946; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=321946

8 July 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
LWLei Hum Wee
Lei Hum Wee
JGJo Ann Andoy Galvan
Jo Ann Andoy Galvan
SPSapna Patil
Sapna Patil
PMPriya Madhavan
Priya Madhavan
DMDinesh Mahalingam
Dinesh Mahalingam
CSChing Sin Siau
Ching Sin Siau
The prevalence of vaping worldwide is showing an upward trend. This study aimed to determine the factors associated with motivation to quit vaping among vapers in the Federal Territory of Kuala Lumpur, Malaysia, through a cross-sectional, purposive sampling study. Respondents were required to complete a questionnaire consisting of vapers’ sociodemographic questions, habitual behavioral pattern questions, the e-Fagerström Test of Nicotine Dependence, the Glover–Nilsson Smoking Behavioral Dependence Questionnaire, perception questions, motivation to quit questions, and withdrawal symptom questions. A total of 311 vapers participated in this study. The majority of the vapers were male (84.6%), younger (18–25 years) (55.3%), and with monthly income less than RM 4000 (USD 868; 83.9%). The level of motivation to quit vaping was found to have a significant association with the perception of vaping being as satisfying as cigarette smoking (p = 0.006) and mild to very strong nicotine dependence (p = 0.001). Participants who recorded moderate and strong habitual vaping behaviors had lower odds of having high motivation to quit vaping compared to those recording slight habitual behaviors (OR = 0.279, 95%CI(0.110–0.708), p = 0.007 and OR = 0.185, 95%CI(0.052–0.654), p = 0.009, respectively). Factors associated with higher motivation to quit vaping could be explored to gain better understanding of how to increase their motivation level for future quit attempts.

2 December 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
NMNor Asiah Muhamad
Nor Asiah Muhamad
NMNur Hasnah Ma'AMor
Nur Hasnah Ma'AMor
IRIzzah Athirah Rosli
Izzah Athirah Rosli
NANik Athirah Farhana Nik Azhan
Nik Athirah Farhana Nik Azhan
NJNurul Hidayah Jamalluddin
Nurul Hidayah Jamalluddin
NJNorli Abd Jabbar
Norli Abd Jabbar
Background: Maternal mental health concerns either during pregnancy or the postpartum period are a public health challenge. Depression, anxiety, and stress can lead to poorer outcomes in the antenatal and postpartum periods. There is evidence that the effect of stress, anxiety, and depression during pregnancy negatively affects fetal neurodevelopment and children’s developmental outcomes. Early diagnosis can improve treatment outcomes and prevent negative impacts on the mother and baby. Identifying risk factors, such as age, socioeconomic status, mental health history, and family dysfunction, and clinical manifestations are important for public health programs. Objective: This study aims to determine the prevalence of depression and associated risk factors among antenatal and postnatal women attending government health clinics in Selangor. Methods: A multicenter cross-sectional study will be conducted among antenatal and postnatal women attending government health clinics (Klinik Kesihatan) in Selangor, Malaysia, from August 1, 2024, to December 31, 2026. We will perform a simple random sampling in all 9 districts in Selangor to select 1 government health clinic in each district. The inclusion criteria for this study are women aged 18 years and older who are either pregnant or delivered a newborn or stillborn child within the preceding 6 weeks. We will use a published screening tool (Edinburgh Postnatal Depression Scale) to determine the level of depression among antenatal and postnatal women. We will also collect data on sociodemographic characteristics, obstetric factors, and psychosocial support. Results: We will obtain ethics approval from the relevant ethics boards prior to data collection. Data will be analyzed using SPSS version 26.0 (IBM Corporation) and we will conduct a descriptive analysis to determine the prevalence of depression. We will calculate the level of depression among antenatal and postnatal women and score it based on a previous study conducted in Malaysia, with a score of ≥12 indicating the presence of depression. The association between depression and risk factors will be determined by multiple logistic regression analysis. P values less than .05 will be considered statistically significant. Conclusions: Depression is one of the mental health complications that may arise following childbirth. Therefore, the findings of this study on the prevalence and associated risk factors of depression among antenatal and postnatal women in Selangor may help women address this challenge and improve maternal mental health during pregnancy and after birth. International Registered Report Identifier (IRRID): PRR1-10.2196/63663

31 March 2023 in Interactive Journal of Medical Research
Verified
Journal Article
Open access
NMNor Asiah Muhamad
Nor Asiah Muhamad
NMNur Hasnah Ma'Amor
Nur Hasnah Ma'Amor
NMNormi Mustapha
Normi Mustapha
FLFatin Norhasny Leman
Fatin Norhasny Leman
IRIzzah Athirah Rosli
Izzah Athirah Rosli
NLNai Ming Lai
Nai Ming Lai
Background: Hematological malignancies disturb the blood, lymph nodes, and bone marrow. Taking medications for treating opportunistic infections (OIs) in these individuals may enhance the risk of medication interaction as well as adverse drug reactions. Objective: This review aims to evaluate the effectiveness of nondrug interventions in reducing OIs among patients with hematological cancers. Methods: The PubMed, CENTRAL (Cochrane Central Register of Controlled Trials), and Embase databases were searched on December 26, 2022, for all randomized controlled trials (RCTs). The primary endpoint was OIs. The quality of included studies was assessed by the Cochrane Risk-of-Bias tool. Results: A total of 6 studies were included in this review with 4 interventions: (1) types of mouthwash received, (2) presence of coating on central venous catheters (CVCs), (3) use of well-fitted masks, and (4) types of diet consumed. The results were presented in 8 different comparisons: (1) chlorhexidine-nystatin versus saline mouth rinse, (2) chlorhexidine versus saline mouth rinse, (3) nystatin versus saline mouth rinse, (4) chlorhexidine silver sulfadiazine–coated CVCs versus uncoated catheters, (5) well-fitted masks versus no mask, (6) amine fluoride-stannous fluoride versus sodium fluoride mouthwash, (7) low-bacterial diet versus standard hospital diet, and (8) herbal versus placebo mouthwash. No clear differences were reported in any of the outcomes examined in the first 3 comparisons. There were also no clear differences in the rate of catheter-related bloodstream infection or insertion site infection between the use of chlorhexidine silver sulfadiazine–coated CVCs versus uncoated catheters in the patients. Further, no significant differences were seen between patients who used a well-fitted mask and those without a mask in the incidence of OI. The all-cause mortality and mortality due to OI were similar between the 2 groups. There was no clear difference in all-cause mortality, although common adverse effects were reported in patients who used sodium fluoride mouthwash compared with those using amine fluoride-stannous fluoride mouthwash. There was no evidence of any difference in the incidence of possible invasive aspergillosis or candidemia between patients who consumed a low-bacterial diet and a standard diet. For the last comparison, no significant difference was seen between patients who received herbal and placebo mouthwash. Conclusions: Very limited evidence was available to measure the effectiveness of nondrug interventions in hematological cancers. The effectiveness of the interventions included in this review needs to be evaluated further in high-quality RCTs in a dedicated setting among patients with hematological malignancies. Trial Registration: PROSPERO International Prospective Register of Systematic Reviews CRD42020169186; https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=169186

17 September 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
NMNor Asiah Muhamad
Nor Asiah Muhamad
NMNur Hasnah Maamor
Nur Hasnah Maamor
IRIzzah Athirah Rosli
Izzah Athirah Rosli
TSTengku Puteri Nadiah Tengku Baharudin Shah
Tengku Puteri Nadiah Tengku Baharudin Shah
NJNurul Hidayah Jamalluddin
Nurul Hidayah Jamalluddin
NINurashikin Ibrahim
Nurashikin Ibrahim
Background: Self-harm is a major public health concern, with prevalence increasing worldwide, particularly after the COVID-19 pandemic and associated lockdown restrictions. Health care workers (HCWs) face various challenges, such as pressures of social and familial responsibilities, a lack of integration within the profession, heavier workload, bullying at the workplace, and limited support in the workplace, that impact their mental health and often lead to self-harm. Objective: We aim to synthesize the evidence on the pooled prevalence of self-harm worldwide and identify risk factors for self-harm among HCWs. Methods: We will conduct a systematic review of observational and experimental studies that investigated the overall prevalence of self-harm among HCWs. We will search the PubMed, PsycINFO, Embase, and CINAHL databases for eligible articles from inception until March 2025 using specific search terms developed using the population, exposure, comparison, and outcome framework. Study selection and reporting will follow the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and the Meta-Analysis of Observational Studies in Epidemiology guidelines. We will contact the corresponding author via email if the required data are not available in the article. After completing the article search, duplicate records will be removed. Titles and abstracts will then be screened according to the inclusion and exclusion criteria, followed by retrieval of the full texts for detailed screening. All the required data for the review, such as names of authors, publication year, prevalence of self-harm, type of profession, associated risk factors to self-harm, and others, will be extracted using a standardized data extraction form. The quality of the studies will be assessed using the Joanna Briggs Institute guidelines based on the study design. Random-effects meta-analysis will be used to derive the pooled prevalence using Stata (version 17.0) software. We will conduct a subgroup meta-analysis on sex, regions, and the type of profession (physicians or nurses). We will also examine the association of risk factors of self-harm with sociodemographic factors to observe their relationship. Both analyses will be performed using RevMan software. Publication bias will be examined using the funnel plot and Egger test. Results: Data analysis is expected to be completed by August 2025, and manuscript preparation is expected to be completed by October 2025. This review is expected to be completed and published by January 2026. Conclusions: We will provide a comprehensive synthesis of the overall prevalence of self-harm among HCWs. We will also provide important information to develop effective strategies for preventing and managing self-harm among HCWs. Trial Registration: PROSPERO CRD42024581791; https://www.crd.york.ac.uk/PROSPERO/view/CRD42024581791 International Registered Report Identifier (IRRID): PRR1-10.2196/67059